Gal3 competitively inhibited insulin by binding to the insulin receptor (IR) and affected its downstream signals, resulting in insulin resistance; thus, an increase in the level of blood glucose could be observed, which would subsequently cause damage to retinal tissues and promote the process of diabetic retinopathy [140]. This evidence concerns the gene INSR and diabetic retinopathy.